ATE394119T1 - Vakzinzusammensetzung gegen malaria - Google Patents

Vakzinzusammensetzung gegen malaria

Info

Publication number: ATE394119T1
Authority: AT; Austria
Prior art keywords: vaccine composition; composition against; against malaria; malaria; vaccine
Prior art date: 1996-08-02

Application number

AT97940062T

Other languages

English (en)

Inventor

Joseph Cohen

Original Assignee

Glaxosmithkline Biolog Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-02

Filing date

1997-07-31

Publication date

2008-05-15

1997-07-31 Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa

2008-05-15 Application granted granted Critical

2008-05-15 Publication of ATE394119T1 publication Critical patent/ATE394119T1/de

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Tropical Medicine & Parasitology (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT97940062T 1996-08-02 1997-07-31 Vakzinzusammensetzung gegen malaria ATE394119T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9616351.4A GB9616351D0 (en)	1996-08-02	1996-08-02	Vaccine composition

Publications (1)

Publication Number	Publication Date
ATE394119T1 true ATE394119T1 (de)	2008-05-15

Family

ID=10797980

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT97940062T ATE394119T1 (de)	1996-08-02	1997-07-31	Vakzinzusammensetzung gegen malaria

Country Status (32)

Country	Link
US (2)	US20020172692A1 (de)
EP (2)	EP1623720A3 (de)
JP (1)	JP2000517295A (de)
KR (1)	KR20000029747A (de)
CN (1)	CN1241639C (de)
AP (1)	AP1166A (de)
AR (1)	AR008799A1 (de)
AT (1)	ATE394119T1 (de)
AU (1)	AU706303B2 (de)
BG (1)	BG63290B1 (de)
BR (1)	BR9710913A (de)
CA (1)	CA2262402A1 (de)
CO (1)	CO4650186A1 (de)
CZ (1)	CZ290826B6 (de)
DE (1)	DE69738672D1 (de)
DZ (1)	DZ2283A1 (de)
EA (1)	EA002167B1 (de)
GB (1)	GB9616351D0 (de)
ID (1)	ID17860A (de)
IL (1)	IL128318A (de)
MA (1)	MA24291A1 (de)
MY (1)	MY116128A (de)
NO (1)	NO319844B1 (de)
OA (1)	OA10969A (de)
PE (1)	PE97298A1 (de)
PL (1)	PL188741B1 (de)
SK (1)	SK282438B6 (de)
TR (1)	TR199900195T2 (de)
UA (1)	UA68336C2 (de)
UY (1)	UY24654A1 (de)
WO (1)	WO1998005355A1 (de)
ZA (1)	ZA976815B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9915204D0 (en) *	1999-06-29	1999-09-01	Smithkline Beecham Biolog	Vaccine
CA2502268A1 (en)	2002-10-23	2004-05-06	Glaxosmithkline Biologicals S.A.	Methods for vaccinating against malaria
KR101176673B1 (ko) *	2003-12-01	2012-08-23	가부시키가이샤 메이지	앤지오텐신 변환 효소 저해 팹티드
GB0513421D0 (en) *	2005-06-30	2005-08-03	Glaxosmithkline Biolog Sa	Vaccines
AP2745A (en) *	2005-08-02	2013-09-30	Novartis Vaccines & Diagnostic	Reducing interference between oil-containing adjuvants and surfactant-containing antigens
GB0614254D0 (en) *	2006-07-18	2006-08-30	Smithkline Beecham Biolog	Vaccine
SG173363A1 (en)	2006-07-18	2011-08-29	Glaxosmithkline Biolog Sa	Vaccines for malaria
EA015964B1 (ru)	2006-09-07	2012-01-30	Глаксосмитклайн Байолоджикалс С.А.	Вакцина
BRPI0815199A2 (pt)	2007-08-13	2015-03-31	Glaxosmithkline Biolog Sa	Uso de um antígeno derivado da proteína circunsporozóite de plasmodium falciparum
US20100272745A1 (en) *	2007-12-21	2010-10-28	Dominique Ingrid Lemoine	Vaccines for malaria
CL2008003875A1 (es) *	2007-12-24	2010-02-05	Glaxosmithkline Biologicals Sa	Particula proteínica inmunógena que comprende una proteína de fusión que comprende secuencias derivadas de una proteina cs de p. vivax y el antigeno s de la hepatitis b y el antigeno s derivado del virus de la hepatitis b; composicion farmaceutica que lo comprende; procedimiento de producción; y su uso para tratar malaria.
US20120015000A1 (en) *	2008-06-30	2012-01-19	David Lanar	Malaria vaccine of self-assembling polypeptide nanoparticles
JP5600170B2 (ja) *	2009-11-05	2014-10-01	アメリカ合衆国	Ｐｌａｓｍｏｄｉｕｍｆａｌｃｉｐａｒｕｍスポロゾイト及び肝臓段階抗原
CA2809463C (en)	2010-09-27	2021-05-25	Crucell Holland B.V.	Heterologous prime boost vaccination regimen against malaria
GB201116248D0 (en)	2011-09-20	2011-11-02	Glaxosmithkline Biolog Sa	Liposome production using isopropanol
EP2780034A1 (de)	2011-11-14	2014-09-24	Crucell Holland B.V.	Heterologe prime-boost-impfung mit auf masernviren basierten impfstoffen
US9169304B2 (en)	2012-05-01	2015-10-27	Pfenex Inc.	Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
CN104338129B (zh) *	2013-07-26	2017-05-24	中国科学院上海巴斯德研究所	雷帕霉素作为疫苗佐剂的用途及制备方法
JP7136777B2 (ja)	2016-12-07	2022-09-13	グラクソスミスクラインバイオロジカルズソシエテアノニム	新規プロセス
GB201621686D0 (en)	2016-12-20	2017-02-01	Glaxosmithkline Biologicals Sa	Novel methods for inducing an immune response
IE20190085A3 (en)	2017-05-30	2023-07-19	Glaxosmithkline Biologicals Sa	Novel methods for manufacturing an adjuvant
EP3717001A1 (de)	2017-12-01	2020-10-07	GlaxoSmithKline Biologicals S.A.	Saponinreinigung
JP7640473B2 (ja)	2019-06-05	2025-03-05	グラクソスミスクラインバイオロジカルズソシエテアノニム	サポニン精製

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0071705B1 (de) *	1981-05-21	1989-11-23	The Wellcome Foundation Limited	Protozoen-Antigen
PT82282B (pt) *	1985-03-28	1988-02-17	Univ New York	Processo de preparacao de um conjugado de proteina de suporte-antigeno imunogenico para uso como vacina contra malaria
GB8819209D0 (en) *	1988-08-12	1988-09-14	Research Corp Ltd	Polypeptide & dna encoding same
GB9012580D0 (en) *	1990-06-06	1990-07-25	Univ Nijmegen	Novel protein
FR2679776A1 (fr) *	1991-07-31	1993-02-05	Pasteur Institut	Melange de constituants peptidiques ayant des proprietes vaccinantes contre le paludisme, notamment du a plasmodium falciparum.
JP3954643B2 (ja) *	1991-11-16	2007-08-08	グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム	マラリア原虫由来のＣＳおよびＨＢｓＡＧ間のハイブリッド蛋白質
US6169171B1 (en) *	1992-02-27	2001-01-02	Smithkline Beecham Biologicals (S.A.)	Hybrid protein between CS from plasmodium and HBSAG
PT761231E (pt) *	1992-06-25	2000-06-30	Smithkline Beecham Biolog	Composicao de vacina contendo adjuvantes
GB9326253D0 (en) *	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
AUPM368994A0 (en) *	1994-02-04	1994-02-24	Saramane Pty Ltd	Malaria merozoite antigen subunit vaccine
FR2744723A1 (fr) *	1996-02-14	1997-08-14	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744724B1 (fr) *	1996-02-14	2002-08-02	Pasteur Institut	Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques

1996
- 1996-08-02 GB GBGB9616351.4A patent/GB9616351D0/en active Pending
1997
- 1997-07-30 DZ DZ970133A patent/DZ2283A1/fr active
- 1997-07-31 ID IDP972672A patent/ID17860A/id unknown
- 1997-07-31 AT AT97940062T patent/ATE394119T1/de not_active IP Right Cessation
- 1997-07-31 CA CA002262402A patent/CA2262402A1/en not_active Abandoned
- 1997-07-31 DE DE69738672T patent/DE69738672D1/de not_active Expired - Fee Related
- 1997-07-31 EP EP05077131A patent/EP1623720A3/de not_active Withdrawn
- 1997-07-31 BR BR9710913A patent/BR9710913A/pt not_active Application Discontinuation
- 1997-07-31 IL IL12831897A patent/IL128318A/en not_active IP Right Cessation
- 1997-07-31 SK SK115-99A patent/SK282438B6/sk unknown
- 1997-07-31 CN CNB971983607A patent/CN1241639C/zh not_active Expired - Fee Related
- 1997-07-31 PL PL97331424A patent/PL188741B1/pl not_active IP Right Cessation
- 1997-07-31 UA UA99010527A patent/UA68336C2/uk unknown
- 1997-07-31 EA EA199900069A patent/EA002167B1/ru not_active IP Right Cessation
- 1997-07-31 KR KR1019997000855A patent/KR20000029747A/ko not_active Ceased
- 1997-07-31 CZ CZ1999292A patent/CZ290826B6/cs not_active IP Right Cessation
- 1997-07-31 TR TR1999/00195T patent/TR199900195T2/xx unknown
- 1997-07-31 WO PCT/EP1997/004326 patent/WO1998005355A1/en active IP Right Grant
- 1997-07-31 AU AU42040/97A patent/AU706303B2/en not_active Ceased
- 1997-07-31 AP APAP/P/1999/001448A patent/AP1166A/en active
- 1997-07-31 MA MA24749A patent/MA24291A1/fr unknown
- 1997-07-31 EP EP97940062A patent/EP0957933B1/de not_active Expired - Lifetime
- 1997-07-31 JP JP10507631A patent/JP2000517295A/ja active Pending
- 1997-07-31 MY MYPI97003495A patent/MY116128A/en unknown
- 1997-07-31 ZA ZA9706815A patent/ZA976815B/xx unknown
- 1997-08-01 PE PE1997000672A patent/PE97298A1/es not_active Application Discontinuation
- 1997-08-01 CO CO97044242A patent/CO4650186A1/es unknown
- 1997-08-01 UY UY24654A patent/UY24654A1/es not_active IP Right Cessation
- 1997-08-01 AR ARP970103502A patent/AR008799A1/es not_active Application Discontinuation
1999
- 1999-02-01 NO NO19990464A patent/NO319844B1/no unknown
- 1999-02-02 BG BG103141A patent/BG63290B1/bg unknown
- 1999-02-02 OA OA9900022A patent/OA10969A/en unknown
2001
- 2001-12-18 US US10/024,860 patent/US20020172692A1/en not_active Abandoned
2006
- 2006-08-11 US US11/463,933 patent/US20060292170A1/en not_active Abandoned

Also Published As

Publication number	Publication date
SK11599A3 (en)	2000-03-13
UY24654A1 (es)	2001-08-27
AP1166A (en)	2003-06-30
DE69738672D1 (de)	2008-06-19
EA199900069A1 (ru)	1999-10-28
AP9901448A0 (en)	1999-03-31
PL331424A1 (en)	1999-07-19
IL128318A0 (en)	2000-01-31
IL128318A (en)	2002-04-21
TR199900195T2 (xx)	1999-04-21
BG103141A (en)	1999-08-31
GB9616351D0 (en)	1996-09-11
AU706303B2 (en)	1999-06-10
MY116128A (en)	2003-11-28
OA10969A (en)	2003-03-04
EP0957933A1 (de)	1999-11-24
CZ290826B6 (cs)	2002-10-16
DZ2283A1 (fr)	2002-12-25
UA68336C2 (en)	2004-08-16
US20020172692A1 (en)	2002-11-21
ID17860A (id)	1998-01-29
NO319844B1 (no)	2005-09-19
AU4204097A (en)	1998-02-25
BR9710913A (pt)	1999-08-17
PL188741B1 (pl)	2005-04-29
BG63290B1 (bg)	2001-09-28
EP1623720A3 (de)	2006-02-22
NO990464D0 (no)	1999-02-01
EA002167B1 (ru)	2002-02-28
CA2262402A1 (en)	1998-02-12
KR20000029747A (ko)	2000-05-25
CN1241639C (zh)	2006-02-15
EP0957933B1 (de)	2008-05-07
EP1623720A2 (de)	2006-02-08
CO4650186A1 (es)	1998-09-03
PE97298A1 (es)	1999-02-14
NO990464L (no)	1999-02-01
JP2000517295A (ja)	2000-12-26
US20060292170A1 (en)	2006-12-28
WO1998005355A1 (en)	1998-02-12
CZ29299A3 (cs)	1999-06-16
AR008799A1 (es)	2000-02-23
ZA976815B (en)	1998-05-11
CN1231613A (zh)	1999-10-13
SK282438B6 (sk)	2002-02-05
MA24291A1 (fr)	1998-04-01

Publication	Publication Date	Title
DE69738672D1 (de)	2008-06-19	Vakzinzusammensetzung gegen malaria
NO20004758D0 (no)	2000-09-22	Vaksinesammensetning
NO20003302L (no)	2000-08-18	Vaksine
DE60045324D1 (de)	2011-01-13	Impfstoffzusammensetzung
DE69933200D1 (de)	2006-10-26	Kombinierte impfstoffzusammensetzungen
BR9711853A (pt)	1999-08-24	Vacinas
DE69800383D1 (de)	2000-12-14	Influenza Vaccine
NO996133D0 (no)	1999-12-10	Olje-i-vann-vaksinesammensetninger
DE69729184D1 (de)	2004-06-24	Vakzine gegen clostridium perfringens
NO985460D0 (no)	1998-11-23	Limsammensetning
DE10199038I2 (de)	2007-01-04	Zusammensetzungen gegen Malaria
EP1083926A4 (de)	2006-01-18	Impfstoff
DE69737583D1 (de)	2007-05-24	Härtbare Zusammensetzung
DE69718759D1 (de)	2003-03-06	Selbstschäumbare Fluorpolymerzusammensetzung
DE69725482D1 (de)	2003-11-20	Härtbare Siliconzusammensetzungen
DK1023035T3 (da)	2002-09-16	Mundplejemiddel
DE69827335D1 (de)	2004-12-09	Härtbare Zusammensetzung
FI972054L (fi)	1997-05-14	Immunogeenisiä koostumuksia
DE69510840D1 (de)	1999-08-26	Härtbare Organopolysiloxanzusammensetzungen
DE69507744D1 (de)	1999-03-25	Hülle gegen Durchbiegung
NO20005599D0 (no)	2000-11-06	Vaksine
EP1105154A4 (de)	2005-03-09	Impfstoffe gegen bakterielle superantigene
ATE333894T1 (de)	2006-08-15	Vakzine gegen infektiöse bursitis
DE69422496D1 (de)	2000-02-10	Mittel gegen malaria
ATE431415T1 (de)	2009-05-15	Hiv impfstoff

Legal Events

Date	Code	Title	Description
2008-11-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties